in8bio.com (INAB) - Volume dodolan perusahaan

IN8bio (INAB) - logo korporat

IN8bio, Inc. (INAB) fully delegates medical testing to external contractors, minimizing operational disruptions. The company's gross sales level on the GURU.Markets daily price chart reflects current dynamics, where the indicator is fixed at 0.00. The business relies on venture capital, ignoring macroeconomic cycles, while the absence of a stable cash flow makes financial results dependent on clinical development milestones.

Pendapatan perusahaan in8bio.com (INAB): kanggo periode 04.07.2022 - 15.11.2026

Rincian analitis perusahaan IN8bio, Inc.

- rega pasar lan target rega analis:
Rega bursa IN8bio, Inc.|INAB - Prakiraan konsensus analis
- indikator kapitalisasi pasar:
Kapitalisasi pasar IN8bio Inc.|INAB - Nilai Perusahaan
- statistik nilai buku emiten:
Aset Bersih saben Saham IN8bio|INAB - Nilai Buku Perusahaan|Rasio Kapitalisasi marang Nilai Buku in8bio.com|INAB - Nilai Agregat Aset
- informasi babagan utang lan solvabilitas:
Total Utang marang Modal IN8bio, Inc.|INAB - Utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal IN8bio, Inc.|INAB - Gunggung kewajiban utang perusahaan|Rasio utang marang kapitalisasi buku IN8bio, Inc.|INAB - Utang jangka dawa|Kewajiban jangka cendhak perusahaan IN8bio|Rasio cepet in8bio.com
- rincian bathi lan kelipatan pasar:
INAB - Asil keuangan resik|Bathi sing dikarepake IN8bio, Inc.|INAB - Pangali rega marang bathi|Pangali Forward P/E IN8bio, Inc|INAB - Pangali rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan IN8bio|INAB - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi resik saben saham (EPS TTM) IN8bio|INAB - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan in8bio.com|INAB - Wutah bathi saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep IN8bio, Inc.
- indikator volume dodolan lan pendapatan:
INAB - Pendapatan lan volume dodolan|Prakiraan volume dodolan in8bio.com|INAB - Rasio rega marang pendapatan|Multiplikator Forward P/S IN8bio Inc
Pambiji fundamental:IN8bio, Inc
Barang utama IN8bio

A comparative asset analysis requires an assessment of daily inflows, which measure the resilience of market demand and signal risks of failing to meet corporate plans. The gross sales volume dynamics reflect the financial stability of IN8bio, Inc. (INAB), where reliance on grants and the success of blood cancer therapy determine the fundamental value of the business, as this chart clearly demonstrates.

Karo sapa IN8bio, Inc. saingan

Total pendapatan perusahaan TG Therapeutics, Inc. TGTX|Pendapatan lan volume dodolan ACLX|Disc Medicine - Volume dodolan perusahaan|Pendapatan perusahaan Syndax Corp SNDX|Pendapatan lan volume dodolan Kura Oncology, Inc. KURA|ADC Therapeutics SA - Pendapatan lan volume dodolan|Total pendapatan perusahaan foghorntx.com|VOR (Vor Biopharma) - Dodolan perusahaan|Nkarta Corp (NKTX) - Pendapatan lan volume dodolan|Pendapatan perusahaan Coeptis|Actinium Corp (ATNM) - Pendapatan reged perusahaan|Pendapatan lan volume dodolan ESLA|CASI (CASI Pharmaceuticals Inc.) - Pendapatan dodolan perusahaan|Pendapatan perusahaan Marker Therapeutics MRKR|Pendapatan lan volume dodolan eternatx.com ERNA|GTBP - Pendapatan perusahaan|Pendapatan dodolan perusahaan APTO (aptose.com)|BPTH: Pendapatan lan volume dodolan|meipharma.com - Pendapatan dodolan perusahaan|Pendapatan perusahaan Vincerx